blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2237785

EP2237785 - TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.10.2016
Database last updated on 15.06.2024
Most recent event   Tooltip08.12.2017Lapse of the patent in a contracting state
New state(s): LU		published on 10.01.2018  [2018/02]
Applicant(s)For all designated states
Emory University
1599 Clifton Rd. NE 4th Floor, 1599-001-1AZ
Atlanta, GA 30322 / US
[2010/41]
Inventor(s)01 / ARBISER, Jack, L.
1690 Parliament Pt.
Atlanta GA 30329 / US
 [2010/41]
Representative(s)Wilson, Gary, et al
HGF Limited
Delta House
50 West Nile Street
Glasgow G1 2NP / GB
[2015/52]
Former [2013/44]Wilson, Gary, et al
Harrison Goddard Foote LLP
Delta House
50 West Nlle Street
Glasgow G1 2NP / GB
Former [2011/20]Harrison Goddard Foote
Delta House 50 West Nlle Street Glasgow
G1 2NP / GB
Former [2010/41]Harrison Goddard Foote
106 Hope Street Glasgow
G2 6PH / GB
Application number, filing date08870156.029.12.2008
[2010/41]
WO2008US88495
Priority number, dateUS2007000974531.12.2007         Original published format: US 9745
US2008009002719.08.2008         Original published format: US 90027
[2010/41]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009088838
Date:16.07.2009
Language:EN
[2009/29]
Type: A2 Application without search report 
No.:EP2237785
Date:13.10.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 16.07.2009 takes the place of the publication of the European patent application.
[2010/41]
Type: B1 Patent specification 
No.:EP2237785
Date:23.12.2015
Language:EN
[2015/52]
Search report(s)International search report - published on:KR08.10.2009
(Supplementary) European search report - dispatched on:EP24.10.2011
ClassificationIPC:A61K31/55, A61P35/00, A61K31/40, A61P27/00, A61P27/06, A61P27/12, A61P33/02, A61P33/06, A61K31/136, A61K31/14, A61K31/353, A61K31/404, A61K31/422, A61K31/428, A61K31/4706, A61K31/4709, C07D223/26, C07F9/40
[2015/32]
CPC:
A61K31/55 (EP,US); A61K31/136 (EP,US); A61K31/14 (EP,US);
A61K31/353 (EP,US); A61K31/404 (EP,US); A61K31/422 (EP,US);
A61K31/428 (EP,US); A61K31/47 (EP,US); A61K31/4706 (EP,US);
A61K31/4709 (EP,US); A61K31/54 (EP,US); A61K31/553 (EP,US);
A61K31/662 (EP,US); A61K9/127 (US); A61P27/00 (EP);
A61P27/02 (EP); A61P27/06 (EP); A61P27/12 (EP);
A61P27/14 (EP); A61P33/00 (EP); A61P33/02 (EP);
A61P33/06 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P35/04 (EP); A61P43/00 (EP); C07D215/26 (EP,US);
C07D215/46 (EP,US); C07D223/26 (EP,US); C07D223/28 (EP,US);
C07D263/32 (EP,US); C07D275/06 (EP,US); C07D279/28 (EP,US);
C07D311/36 (EP,US); C07F9/4056 (EP,US); C07F9/4059 (EP,US);
Y02A50/30 (EP,US) (-)
Former IPC [2011/47]A61K31/55, A61P35/00, A61K31/40, A61P27/00, A61P27/06, A61P27/12, A61P33/02, A61P33/06, A61K31/136, A61K31/14, A61K31/353, A61K31/404, A61K31/422, A61K31/428, A61K31/4706, A61K31/4709
Former IPC [2010/41]A61K31/55, A61P35/00, A61K31/40
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/52]
Former [2010/41]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:TRIARYLMETHAN-ANALOGA UND IHRE VERWENDUNG BEI DER KREBSBEHANDLUNG[2010/41]
English:TRIARYLMETHANE ANALOGS AND THEIR USE IN TREATING CANCERS[2010/41]
French:ANALOGUES DE TRIARYLMÉTHANE ET UTILISATION DE CES DERNIERS DANS LE TRAITEMENT DE CANCERS[2010/41]
Entry into regional phase29.07.2010National basic fee paid 
29.07.2010Search fee paid 
29.07.2010Designation fee(s) paid 
29.07.2010Examination fee paid 
Examination procedure23.10.2009Request for preliminary examination filed
International Preliminary Examining Authority: US
29.07.2010Examination requested  [2010/41]
29.05.2012Amendment by applicant (claims and/or description)
06.12.2012Despatch of a communication from the examining division (Time limit: M04)
28.03.2013Reply to a communication from the examining division
25.03.2015Cancellation of oral proceeding that was planned for 23.04.2015
01.04.2015Despatch of a communication from the examining division (Time limit: M02)
23.04.2015Date of oral proceedings (cancelled)
08.06.2015Reply to a communication from the examining division
10.07.2015Communication of intention to grant the patent
09.11.2015Fee for grant paid
09.11.2015Fee for publishing/printing paid
09.11.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.12.2012
Opposition(s)26.09.2016No opposition filed within time limit [2016/48]
Fees paidRenewal fee
22.12.2010Renewal fee patent year 03
27.12.2011Renewal fee patent year 04
26.12.2012Renewal fee patent year 05
27.12.2013Renewal fee patent year 06
11.12.2014Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.12.2008
AT23.12.2015
BE23.12.2015
BG23.12.2015
CY23.12.2015
CZ23.12.2015
DK23.12.2015
EE23.12.2015
ES23.12.2015
FI23.12.2015
HR23.12.2015
LT23.12.2015
LV23.12.2015
MC23.12.2015
MT23.12.2015
NL23.12.2015
PL23.12.2015
RO23.12.2015
SE23.12.2015
SI23.12.2015
SK23.12.2015
TR23.12.2015
IE29.12.2015
LU29.12.2015
CH31.12.2015
LI31.12.2015
NO23.03.2016
GR24.03.2016
IS23.04.2016
PT26.04.2016
[2018/02]
Former [2017/39]HU29.12.2008
AT23.12.2015
BE23.12.2015
BG23.12.2015
CY23.12.2015
CZ23.12.2015
DK23.12.2015
EE23.12.2015
ES23.12.2015
FI23.12.2015
HR23.12.2015
LT23.12.2015
LV23.12.2015
MC23.12.2015
MT23.12.2015
NL23.12.2015
PL23.12.2015
RO23.12.2015
SE23.12.2015
SI23.12.2015
SK23.12.2015
TR23.12.2015
IE29.12.2015
CH31.12.2015
LI31.12.2015
NO23.03.2016
GR24.03.2016
IS23.04.2016
PT26.04.2016
Former [2017/15]AT23.12.2015
BE23.12.2015
CZ23.12.2015
DK23.12.2015
EE23.12.2015
ES23.12.2015
FI23.12.2015
HR23.12.2015
LT23.12.2015
LV23.12.2015
MC23.12.2015
NL23.12.2015
PL23.12.2015
RO23.12.2015
SE23.12.2015
SI23.12.2015
SK23.12.2015
IE29.12.2015
CH31.12.2015
LI31.12.2015
NO23.03.2016
GR24.03.2016
IS23.04.2016
PT26.04.2016
Former [2017/03]AT23.12.2015
BE23.12.2015
CZ23.12.2015
DK23.12.2015
EE23.12.2015
ES23.12.2015
FI23.12.2015
HR23.12.2015
LT23.12.2015
LV23.12.2015
MC23.12.2015
NL23.12.2015
PL23.12.2015
RO23.12.2015
SE23.12.2015
SK23.12.2015
IE29.12.2015
CH31.12.2015
LI31.12.2015
NO23.03.2016
GR24.03.2016
IS23.04.2016
PT26.04.2016
Former [2016/46]AT23.12.2015
CZ23.12.2015
DK23.12.2015
EE23.12.2015
ES23.12.2015
FI23.12.2015
HR23.12.2015
LT23.12.2015
LV23.12.2015
MC23.12.2015
NL23.12.2015
PL23.12.2015
RO23.12.2015
SE23.12.2015
SK23.12.2015
IE29.12.2015
BE31.12.2015
CH31.12.2015
LI31.12.2015
NO23.03.2016
GR24.03.2016
IS23.04.2016
PT26.04.2016
Former [2016/45]AT23.12.2015
CZ23.12.2015
EE23.12.2015
ES23.12.2015
FI23.12.2015
HR23.12.2015
LT23.12.2015
LV23.12.2015
MC23.12.2015
NL23.12.2015
PL23.12.2015
RO23.12.2015
SE23.12.2015
SK23.12.2015
IE29.12.2015
BE31.12.2015
NO23.03.2016
GR24.03.2016
IS23.04.2016
PT26.04.2016
Former [2016/42]AT23.12.2015
CZ23.12.2015
EE23.12.2015
ES23.12.2015
FI23.12.2015
HR23.12.2015
LT23.12.2015
LV23.12.2015
MC23.12.2015
NL23.12.2015
PL23.12.2015
RO23.12.2015
SE23.12.2015
SK23.12.2015
BE31.12.2015
NO23.03.2016
GR24.03.2016
IS23.04.2016
PT26.04.2016
Former [2016/38]AT23.12.2015
CZ23.12.2015
EE23.12.2015
ES23.12.2015
FI23.12.2015
HR23.12.2015
LT23.12.2015
LV23.12.2015
NL23.12.2015
PL23.12.2015
RO23.12.2015
SE23.12.2015
SK23.12.2015
BE31.12.2015
NO23.03.2016
GR24.03.2016
IS23.04.2016
PT26.04.2016
Former [2016/36]AT23.12.2015
CZ23.12.2015
EE23.12.2015
ES23.12.2015
FI23.12.2015
HR23.12.2015
LT23.12.2015
LV23.12.2015
NL23.12.2015
PL23.12.2015
RO23.12.2015
SE23.12.2015
SK23.12.2015
BE31.12.2015
NO23.03.2016
GR24.03.2016
Former [2016/35]CZ23.12.2015
ES23.12.2015
FI23.12.2015
HR23.12.2015
LT23.12.2015
LV23.12.2015
NL23.12.2015
SE23.12.2015
BE31.12.2015
NO23.03.2016
GR24.03.2016
Former [2016/34]CZ23.12.2015
FI23.12.2015
HR23.12.2015
LT23.12.2015
LV23.12.2015
NL23.12.2015
SE23.12.2015
BE31.12.2015
NO23.03.2016
GR24.03.2016
Former [2016/26]FI23.12.2015
HR23.12.2015
LT23.12.2015
LV23.12.2015
NL23.12.2015
SE23.12.2015
BE31.12.2015
NO23.03.2016
GR24.03.2016
Former [2016/25]FI23.12.2015
HR23.12.2015
LT23.12.2015
LV23.12.2015
SE23.12.2015
BE31.12.2015
NO23.03.2016
GR24.03.2016
Former [2016/24]FI23.12.2015
HR23.12.2015
LT23.12.2015
SE23.12.2015
BE31.12.2015
NO23.03.2016
GR24.03.2016
Former [2016/23]HR23.12.2015
LT23.12.2015
SE23.12.2015
NO23.03.2016
Former [2016/21]LT23.12.2015
NO23.03.2016
Former [2016/20]LT23.12.2015
Documents cited:Search[X]US4170640  (GRIGG GEOFFREY W [AU], et al) [X] 1,2 * column 2, line 46 - column 3, line 24; table 2 *;
 [X]US2003114403  (MIHAIL ADRIAN [US], et al) [X] 1,2 * paragraphs [0020] , [0021] , [0023] , [0035] , [0039] , [0041]; claim - *;
 [XP]WO2008137740  (UNIV EMORY [US], et al) [XP] 1,2* claim - *;
 [X]  - PERRY BETSY N ET AL, "Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice", JOURNAL OF INVESTIGATIVE DERMATOLOGY, (200610), vol. 126, no. 10, ISSN 0022-202X, pages 2316 - 2322, XP002661174 [X] 1,2 * page 2318, column l, paragraph l - page 2319, column l, paragraph 1 * * page 2320, column r, paragraph 2 * * figures 5,6,7,8 *

DOI:   http://dx.doi.org/10.1038/SJ.JID.5700413
International search[A]US3760007  (STEINMAN M);
 [X]US2002123531  (INDIG GUILHERME LUIZ [US], et al);
 [X]  - INDIG, G. L. ET AL., "Effect of Dye Aggregation on Triarylmethane-Mediated Photoinduced Damage of Hexokinase and DNA", JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY, B: BIOLOGY, (2002), vol. 67, no. 3, pages 139 - 148, XP009088162

DOI:   http://dx.doi.org/10.1016/S1011-1344(02)00308-1
Examination   - DICKERT F L ET AL, "SUBSTITUTED 3 3 DIPHENYLPHTHALIDES AS OPTOCHEMICAL SENSORS FOR POLAR SOLVENT VAPORS", ANALYTICAL CHEMISTRY, (1988), vol. 60, no. 14, ISSN 0003-2700, pages 1377 - 1380
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.